Kaanders JH - Search Results

1

Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial.

Nijkamp MM, Span PN, Terhaard CH, Doornaert PA, Langendijk JA, van den Ende PL, de Jong M, van der Kogel AJ, Bussink J, Kaanders JH. Nijkamp MM, et al. Among authors: kaanders jh. Eur J Cancer. 2013 Oct;49(15):3202-9. doi: 10.1016/j.ejca.2013.06.024. Epub 2013 Jul 15. Eur J Cancer. 2013. PMID: 23867129 Free article. Clinical Trial.

2

Accelerated fractionation radiotherapy for laryngeal cancer, acute, and late toxicity.

Kaanders JH, van Daal WA, Hoogenraad WJ, van der Kogel AJ. Kaanders JH, et al. Int J Radiat Oncol Biol Phys. 1992;24(3):497-503. doi: 10.1016/0360-3016(92)91065-u. Int J Radiat Oncol Biol Phys. 1992. PMID: 1399736

3

Conventional radiotherapy combined with carbogen breathing and nicotinamide for malignant gliomas.

van der Maazen RW, Thijssen HO, Kaanders JH, de Koster A, Keyser A, Prick MJ, Grotenhuis JA, Wesseling P, van der Kogel AJ. van der Maazen RW, et al. Among authors: kaanders jh. Radiother Oncol. 1995 May;35(2):118-22. doi: 10.1016/0167-8140(95)01534-n. Radiother Oncol. 1995. PMID: 7569019 Free article.

4

Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: feasibility and toxicity.

Kaanders JH, Pop LA, Marres HA, van der Maazen RW, van der Kogel AJ, van Daal WA. Kaanders JH, et al. Radiother Oncol. 1995 Dec;37(3):190-8. doi: 10.1016/0167-8140(95)01660-0. Radiother Oncol. 1995. PMID: 8746587

5

Administration of nicotinamide during a five- to seven-week course of radiotherapy: pharmacokinetics, tolerance, and compliance.

Kaanders JH, Stratford MR, Liefers J, Dennis MF, van der Kogel AJ, van Daal WA, Rojas A. Kaanders JH, et al. Radiother Oncol. 1997 Apr;43(1):67-73. doi: 10.1016/s0167-8140(96)01896-8. Radiother Oncol. 1997. PMID: 9165139 Free article.

6

Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenografts.

Bussink J, Kaanders JH, Rijken PF, Martindale CA, van der Kogel AJ. Bussink J, et al. Among authors: kaanders jh. Br J Cancer. 1998;77(1):57-64. doi: 10.1038/bjc.1998.9. Br J Cancer. 1998. PMID: 9459146 Free PMC article.

7

Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer.

Kaanders JH, Pop LA, Marres HA, Liefers J, van den Hoogen FJ, van Daal WA, van der Kogel AJ. Kaanders JH, et al. Radiother Oncol. 1998 Aug;48(2):115-22. doi: 10.1016/s0167-8140(98)00043-7. Radiother Oncol. 1998. PMID: 9783882

8

Vascular architecture and microenvironmental parameters in human squamous cell carcinoma xenografts: effects of carbogen and nicotinamide.

Bussink J, Kaanders JH, Rijken PF, Peters JP, Hodgkiss RJ, Marres HA, van der Kogel AJ. Bussink J, et al. Among authors: kaanders jh. Radiother Oncol. 1999 Feb;50(2):173-84. doi: 10.1016/s0167-8140(99)00010-9. Radiother Oncol. 1999. PMID: 10368041

9

Altered fractionation: limited by mucosal reactions?

Kaanders JH, van der Kogel AJ, Ang KK. Kaanders JH, et al. Radiother Oncol. 1999 Mar;50(3):247-60. doi: 10.1016/s0167-8140(99)00012-2. Radiother Oncol. 1999. PMID: 10392810 Review.

10

Clinical outcome and tumour microenvironmental effects of accelerated radiotherapy with carbogen and nicotinamide.

Bussink J, Kaanders JH, Van der Kogel AJ. Bussink J, et al. Among authors: kaanders jh. Acta Oncol. 1999;38(7):875-82. doi: 10.1080/028418699432563. Acta Oncol. 1999. PMID: 10606417

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

279 results

Search Page

Filters